Abstract
Lipoproteins from gram-positive and -negative bacteria, mycoplasma, and shorter synthetic lipopeptide analogues activate cells of the innate immune system via the Toll-like receptor TLR2/TLR1 or TLR2/TLR6 heterodimers. For this reason, these compounds constitute highly active adjuvants for vaccines either admixed or covalently linked. The lanthionine scaffold has structural similarity with the S-(2,3-dihydroxypropyl)cysteine core structure of the lipopeptides. Therefore, lanthionine-based lipopeptide amides were synthesized and probed for activity as potential TLR2 agonists or antagonists. A collection of analytically defined lipolanthionine peptide amides exhibited an inhibitory effect of the TLR2-mediated IL-8 secretion when applied in high molar excess to the agonistic synthetic lipopeptide Pam3Cys-Ser-(Lys)4-OH. Structure-activity relationships revealed the influence of the chirality of the two alpha-carbon atoms, the chain lengths of the attached fatty acids and fatty amines, and the oxidation level of the sulfur atom on the inhibitory activity of the lipolanthionine peptide amides.
References
Oct 31, 1975·Biochimica Et Biophysica Acta·V Braun
Oct 1, 1991·Chemical & Pharmaceutical Bulletin·M KurimuraK Achiwa
Nov 1, 1991·European Journal of Immunology·H SchildH G Rammensee
Jul 1, 1991·Journal of Medicinal Chemistry·J MetzgerU Schmidt
Nov 30, 1989·Nature·K DeresH G Rammensee
Apr 1, 1970·Analytical Biochemistry·E KaiserP I Cook
Jan 15, 1993·Science·A RusticiM Porro
Jun 2, 1997·The Journal of Experimental Medicine·P F MühlradtG Jung
Jul 4, 1997·Journal of Medicinal Chemistry·G OsapayM Goodman
Sep 24, 1998·Infection and Immunity·P F MühlradtG Jung
Mar 6, 1999·Vaccine·I TsunodaG Y Ishioka
Aug 10, 2000·Organic Letters·L Jobron, G Hummel
Aug 8, 2001·The Journal of Biological Chemistry·T M StulnigW Waldhausl
Sep 8, 2001·Nature Immunology·M SchnareR Medzhitov
May 25, 2002·The Journal of Biological Chemistry·Maximilian ZeydaThomas M Stulnig
Dec 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Peter A SielingRobert L Modlin
May 31, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Kimberly A WaltonJudith A Berliner
May 18, 2004·The Journal of Clinical Investigation·Guangxun MengCarsten J Kirschning
Jun 15, 2004·Vaccine·Renate SpohnKarl-Heinz Wiesmüller
Feb 17, 2005·European Journal of Immunology·Maria ManukyanHolger Heine
Citations
Jan 22, 2010·Amino Acids·Weiguang ZengDavid C Jackson
Mar 6, 2012·Journal of Medicinal Chemistry·Deepak B SalunkeSunil A David
Mar 23, 2010·Journal of Medicinal Chemistry·Wenyan WuSunil A David
Oct 31, 2009·The Journal of Antibiotics·Yasuhiro KojimaSatoshi Omura
Jul 31, 2012·Therapeutic Delivery·Yoshio Fujita, Hiroaki Taguchi
May 26, 2012·Pharmacology & Therapeutics·M J Paul-ClarkJ A Mitchell
Jul 7, 2010·Antiviral Research·Shenghua ZhouRobert W Finberg
Feb 17, 2017·Analytical Chemistry·Reza NematiXudong Yao
Feb 20, 2007·The Journal of Biological Chemistry·Andra B SchrommKlaus Brandenburg
Oct 1, 2011·Organic & Biomolecular Chemistry·Alethea B Tabor
May 2, 2018·Chemistry : a European Journal·Thibaut DenoëlAndré Luxen
Jul 4, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Qingjiang Li, Zhongwu Guo
Nov 14, 2019·Journal of Peptide Science : an Official Publication of the European Peptide Society·Kostyantyn KirichenkoJae H Park
Oct 7, 2020·Organic & Biomolecular Chemistry·Miklós BegeAnikó Borbás
Dec 3, 2008·The Journal of Organic Chemistry·Nathaniel I Martin
Oct 3, 2008·Journal of Medicinal Chemistry·Michael Czarniecki
Aug 17, 2019·Journal of Medicinal Chemistry·Benjamin L LuMargaret A Brimble
Nov 6, 2010·Organic Letters·Trent ConroyRichard J Payne
Jul 7, 2021·Bioconjugate Chemistry·Ian W Hamley
Dec 20, 2011·Organic Letters·Carlos AydilloMaría M Zurbano
Mar 23, 2007·Inorganic Chemistry·Haiyang HeLuigi G Marzilli